Amanote Research

Amanote Research

    RegisterSign In

New Perspectives on Biological HDL-targeted Therapies

Expert Opinion on Biological Therapy - United Kingdom
doi 10.1080/14712598.2017.1333597
Full Text
Open PDF
Abstract

Available in full text

Categories
Drug DiscoveryClinical BiochemistryPharmacology
Date

May 25, 2017

Authors
Ilayaraja MuthuramuRuhul AminBart De Geest
Publisher

Informa UK Limited


Related search

New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Journal of Oncology
Oncology
2010English

Old and New Biological Therapies for Psoriasis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

New Targeted Therapies in Spondyloarthritis: What Are the Limits?

Immunotherapy
OncologyAllergyImmunology
2019English

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

2013English

Skin Fragility: Perspectives on Evidence-Based Therapies

Acta Dermato-Venereologica
DermatologyMedicine
2020English

Targeted Biological Therapies for Graves’ Disease and Thyroid-Associated Ophthalmopathy. Focus on B-Cell Depletion With Rituximab

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Expanding Targeted Therapies for NSCLC

Cancer Discovery
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy